MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-MH-19-0006481
Bakul Pharma Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹110.31 Cr
▼ 21% YoY
Net profit · FY 2025
₹8.7 Cr
Net margin 7.9%
EBITDA · FY 2025
₹13.05 Cr
EBITDA margin 11.8%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹9.9 Lakh
Issued & subscribed
Open charges
₹13.5 Cr
Satisfied ₹33.08 Cr
Company age
29 yrs
Est. 1997
Employees · EPFO
92
Provident fund records
About Bakul Pharma Private Limited
Data last updated:
Bakul Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 06 October 1997 and has been in existence for over 29 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH1997PTC111089. Its GSTIN is 24AAACB5067D1Z4 (Gujarat). The company holds 3 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹9.9 Lakh. It is led by directors Madhavi Yogin Majmudar and Yogin Ranjit Majmudar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 16/2 Sterling Centre4Th Floor Dr A B Road Worli, Mumbai, Maharashtra, India – 400018.
As per the financials filed for FY 2025, the company reported a revenue of ₹110.31 Cr, a decline of 21% compared to the previous year. For the same year it recorded a net profit of ₹8.7 Cr (net margin 7.9%) and EBITDA of ₹13.05 Cr (EBITDA margin 11.8%). Revenue has grown at a compounded annual rate (CAGR) of 5% over five years.
The company has about 92 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹13.5 Cr and satisfied charges of ₹33.08 Cr on record. Court records list 5 cases involving the company, including 1 filed by the company and 4 filed against it. The company has 1 deal on record (1 secondary share transfer); the latest was in March 2011. Its 8 peer companies in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 4 smaller; the largest is Godavari Drugs Limited with revenue of ₹114.33 Cr. The company has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 5 overdue payments to 5 micro and small suppliers.
Bakul Pharma Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0006481). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website bakulpharma.com.
Company details
CIN U24230MH1997PTC111089
Registration Number 111089
Incorporation Date 06 October 1997
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-MH-19-0006481
Recognitions & Rankings of Bakul Pharma
Contact details
Bakul Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its website is bakulpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address16/2 Sterling Centre4Th Floor Dr A B Road Worli, Mumbai, Maharashtra, India – 400018
- IndustryPharma, API Manufacturers
To see the full contact details of Bakul Pharma Private Limited, buy the company report.
Comprehensive company report
Bakul Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Bakul Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Bakul Pharma Private Limited, buy the company report.
Financials of Bakul Pharma Private Limited
FY 2025 filings availableBakul Pharma Private Limited reported revenue of ₹110.31 Cr (down 21% YoY) for FY 2025.
Revenue · FY 2025
₹110.31 Cr ▼ 21%
Net profit · FY 2025
₹8.7 Cr margin 7.9%
EBITDA · FY 2025
₹13.05 Cr margin 11.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 21%
5 years · compounded
▲ 5%
EBITDA CAGR growth
1 year
▼ 24%
5 years · compounded
▲ 10%
Revenue fell 21% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 5%. EBITDA fell 24% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹13.05 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹8.7 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 11.8% | ||||
| Net Profit Margin | 7.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Bakul Pharma Private Limited, buy the company report.
Board of directors of Bakul Pharma Private Limited
Bakul Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Madhavi Yogin Majmudar | Director | 16 Jan 1998 | 28 Years 9 Months | Current |
| Yogin Ranjit Majmudar Also directs: Puspaj Investment Company Private Limited, Gulbas Investment Private Limited, Bakul Finechem Research Centre and 1 more | Director | 06 Oct 1997 | 29 Years 0 Months | Current |
Peer comparison
Bakul Pharma Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Godavari Drugs Limited | ₹114.33 Cr (FY 2025) | -27.0% | Secunderabad, Telangana, India | |||
| Archimedis Laboratories Private Limited | ₹114.19 Cr (FY 2025) | 22.0% | Hyderabad, Telangana, India | |||
| Glochem Industries Private Limited | ₹113.55 Cr (FY 2025) | -7.0% | Hyderabad, Telangana, India | |||
| Venkar Chemicals Private Limited | ₹112.58 Cr (FY 2024) | 61.0% | Hyderabad, Telangana, India | |||
| Bakul Pharma Private Limitedthis company | ₹110.31 Cr (FY 2025) | ₹8.7 Cr | 7.9% | -21.0% | 92 | Mumbai, Maharashtra, India |
| Danopharm Private Limited | ₹108.78 Cr (FY 2025) | -7.0% | Mumbai, Maharashtra, India | |||
| Almelo Private Limited | ₹108.05 Cr (FY 2024) | 22.0% | Hyderabad, Telangana, India | |||
| Virdev Intermediates Private Limited | ₹107.72 Cr (FY 2025) | -3.0% | Surat, Gujarat, India | |||
| Panchsheel Organics Limited | ₹107.68 Cr (FY 2024) | 3.0% | Indore, Madhya Pradesh, India |
To see the full peer comparison of Bakul Pharma Private Limited, buy the company report.
Auditor
Bakul Pharma Private Limited is audited by THACKER BUTALA DESAI for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| THACKER BUTALA DESAI | FY 2023 | 110864W |
Shareholding
The shareholding of Bakul Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Bakul Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹13.5 Cr
Satisfied charges
₹33.08 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 20 Oct 2021 | 100495954 | Hdfc Bank Limited | ₹5.5 Cr | Open | |
| 29 Nov 2019 | 100305927 | The Hongkong and Shanghai Banking Corporation Limited | ₹1.5 Cr | Open | |
| 12 Sep 2019 | 100289541 | Hdfc Bank Limited | ₹6.5 Cr | Open | |
| 27 Feb 2019 | 100251125 | The Hongkong and Shanghai Banking Corporation Limited | ₹6 Cr | Satisfied | |
| 19 Jul 2018 | 100199934 | The Hongkong and Shanghai Banking Corporation Limited | ₹10 Lakh | Satisfied |
To see the full charge records of Bakul Pharma Private Limited, buy the company report.
Total charge records: 8 View all charges
Deals & funding
Bakul Pharma Private Limited has 1 deal on record (1 secondary share transfer); the latest was in March 2011.
Total deals
1
Secondary share transfer
1
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2011 | Secondary share transfer | Undisclosed | Buyer: Yogin R Majmudar HUF, 3 individuals Seller: Saga Chemicals Private Limited , Hamsons Laboratories Private Limited , Alpic Pharmaceuticals Private Limited, an individual |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Bakul Pharma Private Limited has 5 court cases on record: 1 filed by Bakul Pharma, 4 filed against it. All cases are disposed.
Total cases
5
Filed by the company
1
Filed against the company
4
Disposed
5
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 3 | 0 |
| High courts | 1 | 1 | 0 |
Cases on record (5 of 5)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai CMM Courts, Maharashtra | Court case (S S) | Filed against the company by Ms Sahashtra Export Pvt. Ltd | Disposed |
| High Court, TAMIL NADU | Court case ((T)CMA(PT)) | Filed against the company by F.Hoffmann-La Roche Ag | Disposed |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Cases) | Filed by the company against an individual | Disposed |
| District court, Bharuch, Gujarat | Criminal complaint | Filed against the company by R.B.Trivedi (Reginal Officer ) Gujarat Pollution Controll Board | Disposed |
| District court, Anand, Gujarat | Court case (SPCS) | Filed against the company by M/S Deep Traders Through Its Authorised Signatory Dipen M. Shah | Disposed |
To see the full case history of Bakul Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Bakul Pharma Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 5 overdue payments to 5 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 5)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| Dayaram Chemicals Private Limited | |||
| Silicon Products Private Associates | |||
| Heetu Chemicals and Alkalies Limited | |||
| an individual supplier |
To see the full MSME payment records of Bakul Pharma Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Bakul Pharma Private Limited has a workforce of 92 employees on its EPFO records as of Apr 07, 2024, across 1 active EPFO establishment.
Employee count
92
Active EPFO establishments
1
Employee growth
4.55%
GST
Bakul Pharma has 3 GST registrations: 1 active and 2 cancelled or inactive.
Total GSTINs
3
Active
1
Cancelled / inactive
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAACB5067D1Z4 | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Bakul Pharma Private Limited, buy the company report.
Recent activity
Bakul Pharma Private Limited has 6 board changes on record since 1997: 4 appointments and 2 cessations. The latest: Anand Vadilal Mehta ceased to be Director on 01 Oct 2009.
AGM
Bakul Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Bakul Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge with Hdfc Bank Limited of Rs. 550.00 Lakh registered on 20 Oct 2021 with Charge ID 100495954 was modified on 06 Mar 2023.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 550.00 Lakh with Charge ID 100495954 was registered on 20 Oct 2021.
Charges
A charge with Hdfc Bank Limited of Rs. 650.00 Lakh registered on 12 Sep 2019 with Charge ID 100289541 was modified on 24 Jun 2021.
Charges
A charge registered on 27 Feb 2019 via Charge ID 100251125 with The Hongkong And Shanghai Banking Corporation Limited was fully satisfied on 13 Dec 2019.
Charges
A charge registered on 19 Jul 2018 via Charge ID 100199934 with The Hongkong And Shanghai Banking Corporation Limited was fully satisfied on 13 Dec 2019.
Charges
A charge registered on 30 May 1999 via Charge ID 90140701 with The Hongkong And Shanghai Banking Corporation Limited was fully satisfied on 13 Dec 2019.
Charges
A charge registered on 10 Sep 1998 via Charge ID 90145962 with The Hongkong And Shanghai Banking Corporation Limited was fully satisfied on 13 Dec 2019.
Charges
A charge with The Hongkong And Shanghai Banking Corporation Limited amounted to Rs. 150.00 Lakh with Charge ID 100305927 was registered on 29 Nov 2019.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 650.00 Lakh with Charge ID 100289541 was registered on 12 Sep 2019.
Charges
A charge with The Hongkong And Shanghai Banking Corporation Limited amounted to Rs. 600.00 Lakh with Charge ID 100251125 was registered on 27 Feb 2019.
13 earlier events are in the company report.
Frequently asked questions
Bakul Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 06 October 1997 (29+ years old) and is registered under CIN U24230MH1997PTC111089.
Bakul Pharma has 2 current directors:
- Madhavi Yogin Majmudar - Director
- Yogin Ranjit Majmudar - Director
The latest financial statements of Bakul Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Bakul Pharma is 24AAACB5067D1Z4, registered in Gujarat. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.
The CIN (Corporate Identification Number) of Bakul Pharma is U24230MH1997PTC111089. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bakul Pharma has 5 court cases on record: 1 filed by the company and 4 filed against it. Most are in the district courts.
Bakul Pharma was incorporated on 06 October 1997, making it 29+ years old. It is registered with the Registrar of Companies, Mumbai.
Bakul Pharma has 1 deal on record (1 secondary share transfer); the latest was in March 2011.
The peers of Bakul Pharma by revenue are Godavari Drugs Limited, Archimedis Laboratories Private Limited, Glochem Industries Private Limited, Venkar Chemicals Private Limited, Danopharm Private Limited and 3 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Anand Vadilal Mehta ceased to be Director on 01 Oct 2009. Davinder Singh Marwah ceased to be Director on 30 Aug 2007. Anand Vadilal Mehta was appointed as Director on 16 Jan 1998. Bakul Pharma has 6 board changes on record in total.
Yes, Bakul Pharma is registered as a medium enterprise under Udyam registration (number: UDYAM-MH-19-0006481).
Bakul Pharma has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 5 overdue payments to 5 micro and small suppliers. The latest return was filed on 29 Jun 2019.